<DOC>
	<DOCNO>NCT00161473</DOCNO>
	<brief_summary>The purpose study see medication call prazosin useful treatment agitation aggression person Alzheimer 's disease ( AD ) type dementia late life .</brief_summary>
	<brief_title>Alzheimer 's Long-Term Care -- Treatment Agitation</brief_title>
	<detailed_description>Although occurrence disruptive agitation behavior likely influence environmental/ interpersonal factor , also likely behaviorally relevant neurobiologic abnormality lower threshold expression behavior Alzheimer 's disease . Because success prazosin treatment Posttraumatic Stress Disorder , thought could use similarly disruptive agitation . Originally design evaluate Alzheimer 's disease patient nurse home , study include outpatient . It 9-week placebo-controlled trial .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>No age limit probable/possible Alzheimer 's disease diagnosis disruptive agitate behavior ( e.g. , irritability , aggression , uncooperativeness , pace ) hypotension concurrent use alpha1blockers delirium , schizophrenia , mania , psychotic symptom . Cardiovascular : unstable angina , recent myocardial infarction , second third degree atrioventricular ( AV ) block , preexist hypotension ( systolic blood pressure le 110 ) orthostatic hypotension Other medical exclusion : chronic renal hepatic failure , unstable medical condition Exclusionary medication : current treatment prazosin , alpha1blockers Current enrollment separate investigational drug trial Psychoactive medication : subject may psychoactive medicationfree partial responder ( subjective assessment refer health care professional ) one psychoactive medication follow class : antipsychotic , anticonvulsant , mood stabilizer , antidepressant , benzodiazepine , buspirone . Partial response define improvement agitate behavior persistence agitate behavior severe enough cause patient distress and/or difficulty caregiving . Although formally rat , improvement equivalent Clinical Global Impression Change ( CGIC ) rating minimal improvement ( improvement notice enough improve patient function caregiver 's practical management patient ) . Psychiatric/behavioral : lifetime schizophrenia ; current delirium , mania , depression , uncontrolled persistent distress psychotic symptom ( hallucination , delusion ) , substance abuse , panic disorder , behavior pose immediate danger patient others result patient uncooperative meet requirement study participation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>double-blind</keyword>
	<keyword>treatment</keyword>
	<keyword>prazosin</keyword>
</DOC>